Ashwagandha

KSM-66 Ashwagandha (Withania somnifera) root extract

Products
3
NIH LiverTox — hepatotoxicity
Category B · Highly likely cause
About LiverTox →

LiverTox Category B. 2019-2024: rising case reports of idiosyncratic hepatitis. Iceland DHPA 2024 advisory; EU scrutiny ongoing. Heightened risk with existing liver disease or concurrent hepatotoxic drugs.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 3 labeled products
Min
150 mg
Typical
250 mg
Max
300 mg
Other forms of Ashwagandha

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Products with caution-level excipients
1

contain KSM-66 Ashwagandha (Withania somnifera) root extract alongside a caution-flagged filler

Top brands carrying KSM-66 Ashwagandha (Withania somnifera) root extract

15 brands rolled up

Products containing KSM-66 Ashwagandha (Withania somnifera) root extract

3 in catalog